Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Juniper is a deep tech venture capital firm established to invest in biotechnology and engineered biology. Founded by Jennifer Kan, PhD, and Michael Luciani, the firm aims to support visionary founders who are transforming life sciences into engineered biology. This transformation unlocks new markets and industries, particularly in manufacturing, mining, food, agriculture, and conservation.
Currently, Juniper manages a portfolio of eight companies and operates with a focus on pre-seed, seed, and seed-plus investment stages. The firm is headquartered in an undisclosed location, and its team includes experts in various fields, enhancing its ability to identify and nurture promising startups. Juniper's commitment to advancing life sciences is evident in its strategic partnerships with entrepreneurs who are at the forefront of innovation.
Juniper invests primarily in platforms for catalyst discovery, biomanufacturing, and various applications of engineered biology. Their investment strategy emphasizes supporting technical founders at the earliest stages of company formation, particularly those who are creating new categories and upgrading production methods. The firm targets sectors such as biotech, healthcare, food-agtech, and mining, aiming to capitalize on breakthroughs in biology, engineering, and computation.
Juniper seeks to partner with entrepreneurs who demonstrate a strong vision and technical expertise. They look for founders who are not only innovative but also capable of executing their ideas effectively. The firm prefers to engage in early-stage investments, which allows them to provide significant support and guidance as companies develop their technologies and business models.
Juniper's portfolio includes eight notable companies, each contributing to advancements in biotechnology and engineered biology:
These companies exemplify Juniper's commitment to investing in transformative technologies that have the potential to reshape industries.
Jennifer Kan, PhD: Founding Partner. Jennifer has a strong background in biotechnology and has led numerous investments in the sector. She holds a PhD in a relevant field and has extensive experience in supporting early-stage companies.
Michael Luciani: Founding Partner. Michael brings a wealth of experience in venture capital and has a track record of successful investments in deep tech. His expertise lies in identifying promising startups and guiding them through the early stages of development.
Mackenzie Scurka: Chief of Staff. Mackenzie plays a crucial role in the firm's operations and supports the investment team in managing portfolio companies. Her background includes experience in startup operations and venture capital.
To pitch to Juniper, founders should visit their website at junipervc.com. The firm prefers detailed pitch decks that include information about the technology, market opportunity, and team qualifications. While specific application forms are not mentioned, a well-structured presentation is crucial.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions can enhance the chances of receiving a timely response, so leveraging connections within the industry is advisable.
Juniper runs a program named Juniper, which focuses on supporting early-stage biotechnology startups. This program aims to provide resources, mentorship, and funding to founders who are working on innovative solutions in the life sciences sector. Eligibility criteria and application details are available on their website.
As of October 2023, Juniper has been actively promoting its mission to support advancements in life sciences and engineered biology. The firm continues to highlight its commitment to partnering with entrepreneurs and fostering innovation across various industries. No specific recent investments or exits have been reported, but Juniper's focus remains on identifying and supporting transformative technologies.
What are Juniper's investment criteria?
Juniper focuses on early-stage investments in biotechnology and engineered biology. They seek technical founders who are creating new categories and improving production methods, particularly in sectors like food, agriculture, healthcare, and mining.
How can I apply or pitch to Juniper?
Founders can pitch their ideas through the Juniper website at junipervc.com. The firm encourages detailed presentations that outline the technology, market potential, and team capabilities.
What makes Juniper different from other venture capital firms?
Juniper specializes in deep tech investments, particularly in engineered biology, which sets them apart from traditional venture capital firms. Their focus on supporting visionary founders at the earliest stages allows them to play a significant role in shaping the companies they invest in.
What is Juniper's geographic scope?
While specific geographic preferences are not detailed, Juniper's focus on biotechnology suggests a willingness to invest in innovative companies regardless of location, as long as they align with their investment thesis.
What is Juniper's post-investment involvement like?
Juniper actively partners with their portfolio companies, providing mentorship, operational support, and access to their network of industry experts. They aim to help founders navigate the challenges of early-stage development.
What is the typical check size for Juniper's investments?
Juniper invests at the pre-seed, seed, and seed-plus stages, although specific check sizes are not disclosed. Their focus on early-stage investments suggests they provide funding that aligns with the needs of startups at these stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.